LDH-A negatively regulates dMMR in colorectal cancer.
In: Cancer science, Jg. 112 (2021-08-01), Heft 8, S. 3050-3063
Online
academicJournal
Zugriff:
Although immune checkpoint inhibitors (ICIs) have achieved unprecedented success in dMMR tumors, pMMR tumors accounting for 85% of colorectal cancer (CRC) cases remain unresponsive. Lactate dehydrogenase A (LDH-A) is the rate-limiting enzyme that catalyzes the transformation of pyruvate to lactate in the process of glycolysis. We investigated the relationship between LDH-A and dMMR with the purpose of exploring the treatment strategy for pMMR CRC patients. We here show that LDH-A can promote the proliferation of dMMR and pMMR CRC cells by positively regulating MMR proteins both in vitro and in vivo. LDH-A inhibition can improve the efficacy of PD-1 blockade in a pMMR CRC xenograft model. A statistical analysis of 186 CRC specimens showed a significant correlation between LDH-A and dMMR status. Moreover, patients with both low LDH-A expression and dMMR exhibited better disease-free survival compared with patients with other combinations. The close correlation of LDH-A and dMMR may offer a promising therapeutic strategy in which the combination of LDH-A inhibitor and ICIs may improve the clinical benefit for pMMR CRC patients.
(© 2021 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association.)
Titel: |
LDH-A negatively regulates dMMR in colorectal cancer.
|
---|---|
Autor/in / Beteiligte Person: | Zhang, Y ; Li, J ; Wang, B ; Chen, T ; Chen, Y ; Ma, W |
Link: | |
Zeitschrift: | Cancer science, Jg. 112 (2021-08-01), Heft 8, S. 3050-3063 |
Veröffentlichung: | 2005- : Oxford : Wiley Publishing on behalf of the Japanese Cancer Association ; <i>Original Publication</i>: Tokyo : Japanese Cancer Association, c2003-, 2021 |
Medientyp: | academicJournal |
ISSN: | 1349-7006 (electronic) |
DOI: | 10.1111/cas.15020 |
Schlagwort: |
|
Sonstiges: |
|